Steris PLC
STE: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$977.00 | Tvvkcmy | Qjtvyzg |
Steris Starts Fiscal Year on the Right Track With Strong Sales Growth and Record (Adjusted) EPS
Narrow-moat Steris had a good start to its 2022 fiscal year, its first as a combined company with Cantel. We are maintaining our $189 fair value estimate, and we see shares as moderately overvalued after the stock’s 12% run since May.